Preparing for China · patient guide

Transitional care in China: a guide for international patients

Transitional care is the planned handover of responsibility between clinical teams, or between hospital and community care, so that treatment continues safely. In China, international patients should confirm who is responsible at each stage, which records travel with them, and how medicines and follow-up are arranged. The receiving clinicians decide whether a transfer is suitable; a coordinator can help with logistics but not clinical decisions.

Go to the practical guidance ↓
AI illustration: A consultation room with a desk holding a tablet, pen, clipboard, towel, and running shoes, with a treatment table and exercise ball in the background and a window showing a pagoda outside.
AI-generated illustration for care planning; not a photograph of a real patient, clinician or hospital, and not a diagnostic image.
In this guide

What transitional care actually covers

Transitional care is not a single department or a product you buy. It describes the period when a patient moves from one care setting to another: from an intensive or surgical ward to a general ward, from hospital to home or hotel, from one hospital to another, or from pediatric to adult services. The defining feature is that responsibility for the patient's care passes from one team to another, and the details of that handover determine whether the move is safe.

For an international patient, the concept matters because the handover often crosses a language and a health-system boundary. The team that treated you may be in China and the team that follows you up may be in your home country, or the reverse. Each side needs enough information to continue care without repeating investigations unnecessarily or missing a step.

A useful way to think about it is in three parts. First, the clinical handover: diagnosis, treatment given, current medicines, pending results and what still needs to be decided. Second, the practical handover: who will see you next, where, and how you will get there. Third, the responsibility handover: which named team is accountable if something goes wrong during the transition period. All three need to be explicit, and the treating clinicians, not a coordinator, decide the clinical content.

The question to settle before you travel: who is responsible when

The most useful question an international patient can ask before committing to care in China is not "which hospital is best" but "who is responsible for me at each point, and what happens between those points?" A hospital may accept you for a procedure, but the period after discharge, before a follow-up appointment, is where gaps appear.

Ask the treating hospital directly what its discharge process involves for international patients. Does it provide a written discharge summary in English, or only in Chinese? Who explains medicine changes before you leave? If you are staying in a hotel rather than a ward, who do you contact if a wound or symptom concerns you? These are administrative and clinical questions the hospital must answer for its own service; they are not universal across China, so confirm them for the specific hospital and department.

It also helps to identify whether your care will involve more than one specialty. Complex cases may move between surgery, oncology, rehabilitation or other teams. A multidisciplinary review can bring two or three relevant specialties together, with the scope and fee agreed first. That review can clarify the plan, but it does not by itself guarantee hospital acceptance or a particular outcome.

Write down, in plain language, the name of the team you are under at each stage and the contact route for problems. If no one can tell you who is responsible between discharge and follow-up, that is a gap worth resolving before you travel, not after.

Records that need to travel with the patient

A handover is only as good as the information in it. For a patient moving between teams, the relevant records typically include the diagnosis and how it was established, imaging and pathology reports, operation notes if surgery has occurred, the current medicine list with doses, known allergies, recent test results, and any pending investigations whose results have not yet returned. The receiving clinician decides which of these are needed and how recent they must be.

International patients often hold some of this themselves. Ask the treating hospital what it will give you at discharge and in what language, and ask the receiving team what it wants to see. Where a document exists only in Chinese, ask whether an English translation or interpreter-supported explanation can be arranged; do not assume a translation is automatic. Keep original reports as well as translations, because a clinician may want to see the source document.

There is a practical limit to what a records-based review can establish. A remote opinion based on documents can comment on the material available, but it cannot examine you, and it does not confirm final eligibility for a procedure or hospital acceptance. If records are incomplete, the useful step is to clarify what is missing and request the relevant documents, not to assume the clinical picture is complete.

For patients with a long or complex history, a short chronological summary that you or your family prepare can help a new team orient quickly. Keep it factual: dates, treatments, current medicines and the main open question. The clinicians will verify it against the source records.

Medicines, prescriptions and continuity across the handover

Medicine continuity deserves its own conversation at every handover, because a gap in prescribing is easy to create and hard to spot afterwards. Before any move, ask for a current medicine list that states the drug name, dose, frequency and reason, and confirm who will prescribe each medicine after the transition. Prescribing decisions belong to licensed clinicians in the receiving setting; a coordinator does not decide them.

If you are bringing medicines into China, or taking Chinese-prescribed medicines home, the rules on what may be carried, in what quantity, and with what documentation are set by customs and regulatory authorities, not by the hospital or a coordination service. Ask the relevant authority and the treating team rather than relying on general advice. Do not stop or change a prescribed medicine on your own during a transition; raise any concern with the clinician responsible.

Ask specifically how a new team will know what you are taking if you cannot speak the language. A written list that the receiving clinician can read is more reliable than a verbal account at a busy appointment. If a medicine is unavailable in the new setting, that is a clinical and supply question for the treating team and pharmacy to resolve, and the answer will depend on the specific medicine and provider.

For patients moving from hospital to home or hotel care in China, confirm who handles follow-up prescriptions and how refills are obtained. These arrangements differ between hospitals and are best confirmed in writing rather than assumed.

Rehabilitation and follow-up after the hospital stage

Many transitions are not about a single move but a sequence: hospital treatment, then rehabilitation, then routine follow-up. Each stage has its own team, and each handover needs the same clarity about records, responsibility and contact routes. Rehabilitation planning in particular depends on an assessment of the individual patient, and the receiving physiotherapist or rehabilitation clinician makes an independent judgement about what is appropriate.

It is reasonable to ask how rehabilitation will be arranged, who will assess you, and whether the plan is written down. Do not assume that the original treating team is the only one able to assess you later; a receiving rehabilitation clinician can form their own view, provided they have the relevant information. What matters is that the information travels and that someone is accountable for the next stage.

Follow-up timing is a clinical decision. Ask the treating team what follow-up it recommends for your situation and how that can be delivered if you have returned home. A remote records-based opinion may help a home team understand what was done in China, but it does not replace an in-person assessment where one is needed.

If your condition changes during a transition, worsening symptoms take priority over travel or administrative plans. Seek local medical assessment rather than waiting for a scheduled appointment.

What a coordination service can and cannot do

A coordination service can help with the non-clinical parts of a transition: matching you to a relevant specialty, requesting appointment registration, helping with hospital navigation and interpretation, and discussing practical arrangements such as accommodation and local transport. ChinaSpecialistCare provides information and non-clinical coordination; diagnosis, prescriptions, suitability, hospital acceptance and treatment decisions belong to the treating hospital and licensed clinicians.

It helps to be clear about what this means in practice. A coordinator can help you ask the right questions and make sure documents reach the right place, but cannot tell you whether a transfer is clinically safe, cannot prescribe, and cannot promise that a hospital will accept you or that a particular treatment is available. Hospital consultation fees, tests, treatment, medicines and rooms are paid to the hospital or relevant provider, and coordination fees are separate.

An initial enquiry is free and does not require buying a proxy consultation. A proxy consultation, where a doctor takes your records to a relevant hospital specialist for a records-based opinion while you remain at home, is optional and not a prerequisite for every appointment or operation. For a complex or cross-specialty case, a multidisciplinary review may be arranged, with the scope and fee agreed first.

The most useful thing you can bring to an initial enquiry is a brief summary: the diagnosis if known, the main question, and what has already been done. You do not need to send a complete medical archive at first contact, and you should not send passport numbers or payment details through an article enquiry.

Rare-disease adult care transition

A practical next step

Before committing to care in China, write down the three handovers you expect: into the treating hospital, out of it, and onward to follow-up. For each, note who is responsible, which records travel, and how you would raise a concern. Then put your main question to the treating team and to any coordination service you use, and ask for the answers in writing where possible.

If you would like help identifying the relevant next step, you can start with a short summary through the enquiry form, email or WhatsApp. The team will check the available information, identify what is missing and suggest a route; this is not a diagnosis or a promise of acceptance. The hospital decides suitability, and the treating clinicians remain responsible for clinical decisions throughout the transition.

Sources & scope of this guide

References and official service information relevant to this guide.

  1. Rare-disease adult care transition

This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.